{
    "eid": "2-s2.0-85132131469",
    "title": "Validation and prognostic value of EZ-ALBI score in patients with intermediate-stage hepatocellular carcinoma treated with trans-arterial chemoembolization",
    "cover-date": "2022-12-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Gastroenterology",
            "@code": "2715",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Easy albumin-bilirubin score",
        "Intermediate-stage hepatocellular carcinoma",
        "Overall survival",
        "Trans-arterial chemoembolization"
    ],
    "authors": [
        "Prooksa Ananchuensook",
        "Supachaya Sriphoosanaphan",
        "Sirinporn Suksawatamnauy",
        "Nipaporn Siripon",
        "Nutcha Pinjaroen",
        "Nopavut Geratikornsupuk",
        "Stephen J. Kerr",
        "Kessarin Thanapirom",
        "Piyawat Komolmit"
    ],
    "citedby-count": 3,
    "ref-count": 30,
    "ref-list": [
        "Management of hepatocellular carcinoma",
        "Hepatocellular carcinoma",
        "A Changing paradigm for the treatment of intermediate-stage hepatocellular carcinoma: Asia-Pacific primary liver cancer expert consensus statements",
        "Piscaglia FJBc",
        "Heterogeneity of patients with intermediate (BCLC B) Hepatocellular Carcinoma: proposal for a subclassification to facilitate treatment decisions",
        "European Association For The Study Of The L, European Organisation For R, Treatment Of C. EASL-EORTC clinical practice guidelines: Management of hepatocellular carcinoma",
        "Assessment of prognosis of cirrhosis",
        "Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach\u2014the ALBI grade",
        "Novel albumin\u2013bilirubin grade-based risk prediction model for patients with hepatocellular carcinoma undergoing chemoembolization",
        "A new ALBI-based model to predict survival after transarterial chemoembolization for BCLC stage B hepatocellular carcinoma",
        "Effect of Transarterial Chemoembolization on ALBI Grade in Intermediate-Stage Hepatocellular Carcinoma: Criteria for Unsuitable Cases Selection",
        "EZ-ALBI Score for predicting hepatocellular carcinoma prognosis",
        "EZ-ALBI score as a new prognostic predictor in hepatocellular carcinoma",
        "Transarterial chemoembolization and radioembolization",
        "Prognostic role of noninvasive liver reserve markers in patients with hepatocellular carcinoma undergoing transarterial chemoembolization",
        "Feasibility of dynamic risk assessment for patients with repeated trans-arterial chemoembolization for hepatocellular carcinoma",
        "Predictors of hepatic decompensation after TACE for hepatocellular carcinoma",
        "Lipiodol transarterial chemoembolization for hepatocellular carcinoma: a systematic review of efficacy and safety data",
        "Zeng YJJotFMA The influence on liver function after transcatheter arterial chemoembolization combined with percutaneous radiofrequency ablation in patients with hepatocellular carcinoma",
        "Deterioration of liver function after transarterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): An exploratory analysis of OPTIMIS\u2014An international observational study assessing the use of sorafenib after TACE",
        "Child-Pugh versus MELD score for the assessment of prognosis in liver cirrhosis: a systematic review and meta-analysis of observational studies",
        "Validation and potential of albumin-bilirubin grade and prognostication in a nationwide survey of 46681 hepatocellular carcinoma patients in Japan: the need for a more detailed evaluation of hepatic function",
        "Albumin-bilirubin (ALBI) grade as part of the evidence-based clinical practice guideline for HCC of the Japan Society of Hepatology: a comparison with the liver damage and Child-Pugh classifications",
        "Comparison of 10 noninvasive models for predicting overall survival in patients with intermediate-stage hepatocellular carcinoma",
        "Predictive outcomes using child-turcotte-pugh and albumin-bilirubin scores in patients with hepatocellular carcinoma undergoing transarterial chemoembolization",
        "Applicability of scoring systems predicting outcome of transarterial chemoembolization for hepatocellular carcinoma",
        "Hepatocellular carcinoma survival by etiology: A SEER-medicare database analysis"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Chonburi",
            "@id": "111005067",
            "affilname": "Queen Savang Vadhana Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/111005067",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Ratchadapiseksompotch Fund",
        "Ratchadaphiseksomphot Endowment Fund",
        "Faculty of Medicine, Chulalongkorn University"
    ]
}